G01N 2333/3156
From streptococcus pneumoniae [pneumococcus]
Official title: from Streptococcus pneumoniae [Pneumococcus]
G01N2333/3156 (From streptococcus pneumoniae [pneumococcus]) appears on 34 US grants and 58 published applications in this corpus.
Search patents in G01N- Granted patents
- 34
- Published applications
- 58
- Assignees
- 35
- Inventors
- 132
- Latest grant
- 8 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 4 |
| 2012 | 2 | 1 |
| 2013 | 3 | 4 |
| 2014 | 1 | 3 |
| 2015 | 1 | 3 |
| 2016 | 3 | 9 |
| 2017 | 3 | 5 |
| 2018 | 3 | 4 |
| 2019 | 5 | 3 |
| 2020 | 4 | 2 |
| 2021 | 2 | 4 |
| 2022 | 0 | 1 |
| 2023 | 2 | 2 |
| 2024 | 0 | 7 |
| 2025 | 1 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Human Streptococcus pneumoniae antibodies and uses therefor8 Jul 2025US 12,352,749 B2Oklahoma Medical Research Foundation
- Devices and assays for diagnosis of viral and bacterial infections16 May 2023US 11,650,213 B2Entvantage Diagnostics, Inc.
- Human Streptococcus pneumoniae antibodies and uses therefor31 Jan 2023US 11,567,077 B2Oklahoma Medical Research Foundation
- Streptococcus pneumoniae vaccine30 Mar 2021US 10,960,066 B2Tsinghua University
- Devices and methods for diagnosis of sinusitis16 Feb 2021US 10,921,320 B2Entvantage Diagnostics, Inc.
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Anti-microbial antibody signatures related to lung tumors and uses thereof9 Jul 2026US 2026/0194524 A1Arizona Board of Regents on behalf of Arizona State University
- Streptococcus pneumoniae serotype specific pcr pad assay14 Nov 2024US 2024/0376552 A1Merck Sharp & Dohme Corp.
- Streptococcus pneumoniae serotype-specific detection assay, reagents and kits10 Oct 2024US 2024/0337656 A1Merck Sharp & Dohme Corp.
- Septapeptides associated with neurodegeneracy25 Jul 2024US 2024/0248100 A1Septa Therapeutics, Inc.
Most cited
By later US patents
- Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies28US 6,824,997 B1Binax, Inc. · 2004
- Method of diagnosing pneumonia by detecting a volatile organic compound22US 9,657,326 B2Meon Medical Solutions GmbH & Co KG · 2017
- Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions17US 7,569,223 B2The Rockefeller University · 2009
- LICC of Streptococcus pneumoniae12US 6,110,899 ASmithKline Beecham Corporation · 2000
- LicC11US 6,303,571 B12001